TYROSINE KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY
摘要
<p>The present invention relates to tyrosine kinase inhibitors that contain a zinc-binding moiety and their use in the treatment of tyrosine related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.</p>
